CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 10 of 15

Annals of the Rheumatic Diseases

Briefs 361–400 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    2023 EULAR classification criteria for hand osteoarthritis

    Guideline or statementOsteoarthritis

  2. Ann Rheum Dis

    Allogenic bone marrow–derived mesenchymal stromal cell–based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)

    Randomized controlled trialFibromyalgia & pain

  3. Ann Rheum Dis

    Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis

    Mechanistic studyVasculitis & PMR

  4. Ann Rheum Dis

    Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

    Randomized controlled trialLupus & APS

  5. Ann Rheum Dis

    Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry

    Cohort studyAcross diseases

  6. Ann Rheum Dis

    Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis

    Mechanistic studyOsteoarthritis

  7. Ann Rheum Dis

    Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations

    Research articleLupus & APS

  8. Ann Rheum Dis

    Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

    Meta-analysisRA

  9. Ann Rheum Dis

    Pathological autoantibody internalisation in myositis

    Mechanistic studyMyositis

  10. Ann Rheum Dis

    Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

    Cohort studySystemic sclerosis

  11. Ann Rheum Dis

    Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group

    Guideline or statementVasculitis & PMR

  12. Ann Rheum Dis

    Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

    Randomized controlled trialSpondyloarthritis & PsA

  13. Ann Rheum Dis

    Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial

    Randomized controlled trialVasculitis & PMR

  14. Ann Rheum Dis

    2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases

    Guideline or statementAcross diseases

  15. Ann Rheum Dis

    BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

    Research articleLupus & APS

  16. Ann Rheum Dis

    Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology

    Mechanistic studyLupus & APS

  17. Ann Rheum Dis

    CD8+ tissue-resident memory T cells are expanded in primary Sjögren's disease and can be therapeutically targeted by CD103 blockade

    Mechanistic studySjögren's & overlap

  18. Ann Rheum Dis

    Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease

    Cohort studyRA

  19. Ann Rheum Dis

    Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

    Cohort studyAutoinflammatory & rare

  20. Ann Rheum Dis

    Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set

    Randomized controlled trialRA

  21. Ann Rheum Dis

    Gout risk in adults with pre-diabetes initiating metformin

    Cohort studyGout & crystals

  22. Ann Rheum Dis

    Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus

    Case-control studyLupus & APS

  23. Ann Rheum Dis

    Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout

    Secondary analysisGout & crystals

  24. Ann Rheum Dis

    Patient research partner involvement in rheumatology research: a systematic literature review informing the 2023 updated EULAR recommendations for the involvement of patient research partners

    Research article

  25. Ann Rheum Dis

    Predictors for severe persisting pain in rheumatoid arthritis are associated with pain origin and appraisal of pain

    Cohort studyRA

  26. Ann Rheum Dis

    Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Cohort studyLupus & APS

  27. Ann Rheum Dis

    m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease

    Mechanistic studySjögren's & overlap

  28. Ann Rheum Dis

    Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage

    Mechanistic studyMyositis

  29. Ann Rheum Dis

    ASAS consensus definition of early axial spondyloarthritis

    Guideline or statementSpondyloarthritis & PsA

  30. Ann Rheum Dis

    bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease

    Cohort studyAutoinflammatory & rare

  31. Ann Rheum Dis

    Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis

    Mechanistic studySystemic sclerosis

  32. Ann Rheum Dis

    Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS

    Cohort studyAutoinflammatory & rare

  33. Ann Rheum Dis

    Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

    Mechanistic studyLupus & APS

  34. Ann Rheum Dis

    Identification and validation of anti-protein arginine methyltransferase 5 (PRMT5) antibody as a novel biomarker for systemic sclerosis (SSc)

    Diagnostic or prognostic studySystemic sclerosis

  35. Ann Rheum Dis

    Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years

    Research articleRA

  36. Ann Rheum Dis

    Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

    Cohort studyRA

  37. Ann Rheum Dis

    Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology

    Diagnostic or prognostic studySjögren's & overlap

  38. Ann Rheum Dis

    Systematic literature review to inform the EULAR recommendations for the use of imaging in crystal-induced arthropathies in clinical practice

    Research articleGout & crystals

  39. Ann Rheum Dis

    Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease

    Diagnostic or prognostic studyRA

  40. Ann Rheum Dis

    Changes in alcohol intake and serum urate changes: longitudinal analyses of annual medical examination database

    Cohort studyGout & crystals

All 596 Briefs in ExploreShowing Briefs 361–400 of 596, newest first